Evidence map›Paper›PMID 32461283›Full record

ArticleJournal of clinical microbiology2020

Development and Evaluation of a New Triplex Immunoassay That Detects Group A

Alana L Whitcombe, Paulina Hanson-Manful, Susan Jack, Arlo Upton, Polly Atatoa Carr, Deborah A Williamson, Michael G Baker, Thomas Proft, Nicole J Moreland

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Serological Responses toOpen forum infectious diseases · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Alana L WhitcombeSchool of Medical Sciences, The University of Auckland, Auckland, New Zealand.
Paulina Hanson-ManfulSchool of Medical Sciences, The University of Auckland, Auckland, New Zealand.
Susan JackSouthern District Health Board, Dunedin, New Zealand.
Arlo UptonSouthern Community Laboratories, Dunedin, New Zealand.
Polly Atatoa CarrWaikato District Health Board, Hamilton, New Zealand.
Deborah A WilliamsonPeter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.ORCID 0000-0001-7363-6665
Michael G BakerMaurice Wilkins Centre for Biodiscovery, The University of Auckland, Auckland, New Zealand.
Thomas ProftSchool of Medical Sciences, The University of Auckland, Auckland, New Zealand.ORCID 0000-0002-9275-5042
Nicole J MorelandSchool of Medical Sciences, The University of Auckland, Auckland, New Zealand n.moreland@auckland.ac.nz.
University of Auckland · NZPeter Doherty Institute · AUSouthern Community Laboratories (New Zealand) · NZSouthern District Health Board · NZWaikato District Health Board · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcal serology is a cornerstone in the diagnosis of acute rheumatic fever (ARF), a postinfectious sequela associated with group A

Indexed as

Rheumatic FeverStreptococcal InfectionsAntibodies, BacterialHumansImmunoassayStreptococcus pyogenesAntibodies, Bacterialacute rheumatic feverDNaseBgroup A streptococcusimmunoassayserologySpnAstreptolysin O

Identifiers

PMID32461283
PMCPMC7448642
OpenAlexW3029341614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.